Alembic Pharmaceuticals informs about annual secretarial compliance report

12 May 2022 Evaluate

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, Alembic Pharmaceuticals has informed that it enclosed the Annual Secretarial Compliance Report issued by Samdani Shah & Kabra, Practicing Company Secretaries, for the financial year ended 31st March, 2022.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1126.75 43.45 (4.01%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.